ARID3a from the ARID family: structure, role in autoimmune diseases and drug discovery

Acta Pharmacol Sin. 2023 Nov;44(11):2139-2150. doi: 10.1038/s41401-023-01134-2. Epub 2023 Jul 24.

Abstract

The AT-rich interaction domain (ARID) family of DNA-binding proteins is a group of transcription factors and chromatin regulators with a highly conserved ARID domain that recognizes specific AT-rich DNA sequences. Dysfunction of ARID family members has been implicated in various human diseases including cancers and intellectual disability. Among them, ARID3a has gained increasing attention due to its potential involvement in autoimmunity. In this article we provide an overview of the ARID family, focusing on the structure and biological functions of ARID3a. It explores the role of ARID3a in autoreactive B cells and its contribution to autoimmune diseases such as systemic lupus erythematosus and primary biliary cholangitis. Furthermore, we also discuss the potential for drug discovery targeting ARID3a and present a plan for future research in this field.

Keywords: ARID; ARID3a; autoimmune diseases; primary biliary cholangitis; systemic lupus erythematosus; transcription factors.

Publication types

  • Review

MeSH terms

  • Autoimmune Diseases* / drug therapy
  • Autoimmune Diseases* / metabolism
  • B-Lymphocytes / metabolism
  • DNA-Binding Proteins / genetics
  • DNA-Binding Proteins / metabolism
  • Humans
  • Transcription Factors* / genetics
  • Transcription Factors* / metabolism

Substances

  • Transcription Factors
  • DNA-Binding Proteins